Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
Capricor Therapeutics Inc. (CAPR) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
10865 ROAD TO THE CURE SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2026 MRQ | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 318,129 | 151,500 | 39,500 | 41,400 | 34,885 | 32,666 | |||
| Cash and cash equivalent | 287,847 | 11,287 | 14,695 | 9,603 | 34,885 | 32,666 | |||
| Short-term investments | 30,282 | 140,229 | 24,793 | 31,818 | |||||
| Other undisclosed cash, cash equivalents, and short-term investments | (16) | 12 | (21) | ||||||
| Receivables | 59 | 10,368 | 10,372 | 548 | 392 | ||||
| Other undisclosed current assets | 4,752 | 1,517 | 983 | 941 | 1,160 | 1,011 | |||
| Total current assets: | 322,940 | 163,385 | 50,855 | 42,889 | 36,437 | 33,677 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 13,538 | 1,313 | 2,050 | 2,350 | 2,822 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 18,312 | 5,562 | 5,561 | 4,588 | 1,796 | 851 | |||
| Intangible asset, including goodwill, after accumulated amortization | (260) | 2 | |||||||
| Intangible asset, excluding goodwill, after accumulated amortization | (260) | 2 | |||||||
| Other undisclosed noncurrent assets | 1,159 | 222 | 268 | 268 | 535 | 89 | |||
| Total noncurrent assets: | 33,010 | 7,096 | 7,879 | 7,206 | 4,893 | 942 | |||
| TOTAL ASSETS: | 355,949 | 170,481 | 58,734 | 50,095 | 41,330 | 34,619 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 17,212 | 8,191 | 6,223 | 4,835 | 3,116 | 2,725 | |||
| Accounts payable | 1,655 | ||||||||
| Accrued liabilities | 15,558 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 8,191 | 6,223 | 4,835 | 3,116 | 2,725 | ||||
| Deferred revenue | 12,000 | 12,000 | 24,270 | 17,981 | |||||
| Debt | 247 | ||||||||
| Other liabilities | 27 | ||||||||
| Due to related parties | ✕ | ✕ | ✕ | ✕ | 89 | ||||
| Government assistance, liability | 6,422 | ✕ | ✕ | ✕ | ✕ | ||||
| Other undisclosed current liabilities | 202 | 835 | 749 | 682 | 1,017 | ||||
| Total current liabilities: | 35,837 | 21,026 | 31,270 | 23,587 | 4,133 | 2,971 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3,376 | 3,376 | 2,453 | 71 | |||||
| Long-term debt, excluding current maturities | 3,376 | 3,376 | 71 | ||||||
| Liabilities, other than long-term debt | 14,320 | 3,993 | 1,487 | 11,346 | |||||
| Deferred revenue | 9,468 | ||||||||
| Operating lease, liability | 14,320 | 616 | 1,487 | 1,878 | 2,453 | ||||
| Government assistance, liability | 3,376 | ✕ | ✕ | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 924 | 3,376 | |||||||
| Total noncurrent liabilities: | 14,320 | 3,993 | 4,863 | 14,722 | 5,829 | 3,448 | |||
| Total liabilities: | 50,157 | 25,019 | 36,133 | 38,309 | 9,962 | 6,419 | |||
| Equity | |||||||||
| Equity, attributable to parent | 305,792 | 145,462 | 22,601 | 11,786 | 31,368 | 28,200 | |||
| Common stock | 57 | 46 | 31 | 25 | 24 | 21 | |||
| Additional paid in capital | 610,330 | 344,224 | 181,702 | 148,735 | 139,404 | 116,217 | |||
| Accumulated other comprehensive income (loss) | 283 | 1,027 | 236 | 105 | |||||
| Accumulated deficit | (304,878) | (199,835) | (159,367) | (137,080) | (108,060) | (88,038) | |||
| Total equity: | 305,792 | 145,462 | 22,601 | 11,786 | 31,368 | 28,200 | |||
| TOTAL LIABILITIES AND EQUITY: | 355,949 | 170,481 | 58,734 | 50,095 | 41,330 | 34,619 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2026 TTM | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 45 | 22,270 | 25,178 | 2,551 | 245 | 310 | ||
| Other income | 45 | 7 | 68 | 191 | 548 | |||
| Gross profit: | 45 | 22,270 | 25,178 | 2,551 | 245 | 310 | ||
| Operating expenses | (108,142) | (64,835) | (49,256) | (32,249) | (21,183) | (14,000) | ||
| Other undisclosed operating loss | (45) | |||||||
| Operating loss: | (108,142) | (42,565) | (24,078) | (29,697) | (20,938) | (13,690) | ||
| Nonoperating income | 3,100 | 2,098 | 1,790 | 678 | 916 | 33 | ||
| Investment income, nonoperating | 6,258 | 2,203 | 1,729 | 522 | 57 | 33 | ||
| Interest and debt expense | (3,046) | |||||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (108,088) | (40,4 | ||||||